1 Min Read
May 3 (Reuters) - ESPERITE NV:
* ESPERITE’S CELL FACTORY RECEIVED EUROPEAN FUNDING TO DEVELOP 2ND GENERATION EVS DRUG FOR TREATMENT OF STROKE Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.